Jiangsu Yahong Meditech Co., Ltd. engages in the research, development, production and commercialization of medicines in the fields of urogenital system tumors and other major diseases fields. It provides patients with integrated solutions for diagnosis and treatment. The company's products include APL-1202, APL-1501, APL-1706, APL-1702, ASN-1764, ASN-1780, APL-1901, APL-1401, and ASN-1733. Jiangsu Yahong Meditech was founded by Ke Pan and Cheng Rui Zhuang on March 16, 2010 and is headquartered in Shanghai, China.